Volume 12, Number 10—October 2006
Dispatch
Scrub Typhus in Himalayas
Table 2
Clinical feature* | Men (n = 13) | Women (n = 8) | Total (%) |
---|---|---|---|
Fever | 13 | 8 | 21 (100) |
Chills and rigor | 10 | 5 | 15 (71.4) |
Vomiting | 6 | 3 | 9 (42.8) |
Myalgia | 4 | 4 | 8 (38.0) |
Headache | 4 | 4 | 8 (38.0) |
Altered sensorium | 2 | 3 | 5 (23.8) |
Lymphadenopathy | 9 | 2 | 11 (52.3) |
Jaundice | 5 | 6 | 11 (52.3) |
Hepatomegaly | 6 | 3 | 9 (42.8) |
Congested eyes | 5 | 2 | 7 (33.3) |
Splenomegaly | 4 | 3 | 7 (33.3) |
Abdominal pain | 2 | 4 | 6 (28.5) |
Seizures | 2 | 2 | 4 (19.0) |
Cough | 2 | 2 | 4 (19.0) |
Abnormal bleeding | 1 | 2 | 3 (14.2) |
Eschar | 2 | 0 | 2 (9.5) |
Meningeal signs | 1 | 1 | 2 (9.5) |
Rash | 2 | 0 | 2 (9.5) |
Elevated transaminase levels | 7 | 7 | 14 (66.7) |
Renal dysfunction | 8 | 6 | 14 (66.7) |
Proteinuria | 5 | 3 | 8 (38.1) |
CSF abnormalities† | 1 | 2 | 3 (14.3) |
Acute RDS | 1 | 1 | 2 (9.5) |
*CSF, cerebrospinal fluid; RDS, respiratory distress syndrome.
†Elevated protein level and increased lymphocyte count.
Page created: November 10, 2011
Page updated: November 10, 2011
Page reviewed: November 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.